IN THE PRESS
Press Releases
Read all Press Releases-
-
Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease
-
Alltrna Engineers tRNA Oligonucleotide with Improved Potency and Activity for In Vivo Readthrough of Premature Termination Codons
-
Alltrna Appoints Caroline Kӧhrer, Ph.D., Vice President, Discovery Platform
-
Alltrna Expands Leadership Team with Appointment of Joanne Protano as Chief Financial Officer
-
GEN Edge: No-nonsense - Alltrna Touts tRNA Therapeutics to Treat Thousands of Diseases
-
NYSE The Cure(ious): The Future of Health
-
PharmaVoice Woman of the Week Podcast: Alltrna’s Michelle Werner
-
C&EN: 10 Start-Ups to Watch for 2022
-
Business Insider: Meet the 23 biotech startups that are set to take off in the next 12 months, according to top VCs